Wound care firm gets $25m series B and new CEO:
This article was originally published in Clinica
PolyRemedy, an Irvine, California company developing a system that can fabricate wound dressings at point of care, has clinched $25m in new capital. Co-leading the series B round were Advanced Technology Ventures (ATV) and IDG Ventures. Other investors that took part in the financing included Harris & Harris Group and existing PolyRemedy shareholder Medventure Associates. In conjunction with the investment, Tom Rodgers from ATV and Michael Greeley from IDG Ventures join the company as board directors. PolyRemedy's robotic system is designed to produce customised, pre-assembled wound dressings at the point of care. The dressings, based on a nano-material, are intended for use on chronic wounds such as diabetic ulcers.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.